(Q34424847)

2 August 2017

title

Divalproex sodium in migraine prophylaxis: a dose-controlled study (English)

1 reference

2 August 2017

1 reference

0 references

J Klapper

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

2 August 2017

1 reference

2 August 2017

volume

17

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

103-108

1 reference

Cerebrospinal fluid gamma aminobutyric acid levels in migraine

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702103.X

Neuroexcitatory plasma amino acids are elevated in migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702103.X

Valproate: a new drug in migraine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702103.X

Migraine prophylaxis with divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702103.X

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702103.X

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702103.X

10.1046/J.1468-2982.1997.1702103.X

21 January 2018

Identifiers

DOI

1 reference

release_277qh36xzbgntmpwel7ly3yqua

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/277qh36xzbgntmpwel7ly3yqua

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference